L‑mimosine induces caspase‑9‑mediated apoptosis in human osteosarcoma cells

Xu,Yiwen; Cai,Lin

doi:10.3892/mmr.2018.8403

L‑mimosine induces caspase‑9‑mediated apoptosis in human osteosarcoma cells

Authors:
- Yiwen Xu
- Lin Cai
View Affiliations

Affiliations: Department of Orthopedics, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, P.R. China
Published online on: January 9, 2018 https://doi.org/10.3892/mmr.2018.8403
Pages: 4695-4701

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

L-mimosine is a rare plant amino acid extracted from Mimosa or Leucaena spp., and it has been reported to exhibit antitumor activity in a number of types of cancer. However, the underlying mechanisms remain to be clarified. In the present study, the effect of L‑mimosine was investigated in human osteosarcoma cells. A Cell Counting Kit‑8 assay and flow cytometry were used for toxicity detection. Hoechst staining and transmission electron microscopy (TEM), in addition to western blot analysis, were used for the examination of the associated mechanisms. The results of the present study indicated that L‑mimosine significantly inhibited cell proliferation by inducing cellular apoptosis in osteosarcoma cells. The Hoechst staining results and TEM revealed that nuclear damage increased with the concentration increase in L‑mimosine, as did the formation of apoptotic bodies. Additionally, the results of the western blot analysis confirmed that the treatment of cells with L‑mimosine was accompanied by increasing expression of cleaved caspase‑9. L‑mimosine‑induced apoptosis was inhibited by the caspase‑9 inhibitor Z‑LEHD‑FMK. In addition, the extracellular signal‑regulated kinase (ERK) signaling pathway was suppressed following treatment with L‑mimosine. In conclusion, the results of the present study suggested that L‑mimosine induced apoptosis via the mitochondrial apoptotic pathway. The ERK signaling pathway was indicated to be an additional mechanism underlying apoptosis induction. The results provided evidence for the use of L‑mimosine as a promising candidate for osteosarcoma therapy.

View Figures

View References

1	Picci P: Osteosarcoma (osteogenic sarcoma). Orphanet J Rare Dis. 2:62007. View Article : Google Scholar : PubMed/NCBI
2	Ferrari S and Palmerini E: Adjuvant and neoadjuvant combination chemotherapy for osteogenic sarcoma. Curr Opin Oncol. 19:341–346. 2007. View Article : Google Scholar : PubMed/NCBI
3	Marina N, Gebhardt M, Teot L and Gorlick R: Biology and therapeutic advances for pediatric osteosarcoma. Oncologist. 9:422–441. 2004. View Article : Google Scholar : PubMed/NCBI
4	Chung LC, Tsui KH, Feng TH, Lee SL, Chang PL and Juang HH: L-Mimosine blocks cell proliferation via upregulation of B-cell translocation gene 2 and N-myc downstream regulated gene 1 in prostate carcinoma cells. Am J Physiol Cell Physiol. 302:C676–C685. 2012. View Article : Google Scholar : PubMed/NCBI
5	Zalatnai A and Bocsi J: Mimosine, a plant-derived amino acid induces apoptosis in human pancreatic cancer xenografts. Anticancer Res. 23:4007–4009. 2003.PubMed/NCBI
6	Kulp KS and Vulliet PR: Mimosine blocks cell cycle progression by chelating iron in asynchronous human breast cancer cells. Toxicol Appl Pharmacol. 139:356–364. 1996. View Article : Google Scholar : PubMed/NCBI
7	Hughes TA and Cook PR: Mimosine arrests the cell cycle after cells enter S-phase. Exp Cell Res. 222:275–280. 1996. View Article : Google Scholar : PubMed/NCBI
8	Hwang HS, Davis TW, Houghton JA and Kinsella TJ: Radiosensitivity of thymidylate synthase-deficient human tumor cells is affected by progression through the G1 restriction point into S-phase: Implications for fluoropyrimidine radiosensitization. Cancer Res. 60:92–100. 2000.PubMed/NCBI
9	Lalande M: A reversible arrest point in the late G1 phase of the mammalian cell cycle. Exp Cell Res. 186:332–339. 1990. View Article : Google Scholar : PubMed/NCBI
10	Mosca PJ, Dijkwel PA and Hamlin JL: The plant amino acid mimosine may inhibit initiation at origins of replication in Chinese hamster cells. Mol Cell Biol. 12:4375–4383. 1992. View Article : Google Scholar : PubMed/NCBI
11	Gilbert DM, Neilson A, Miyazawa H, DePamphilis ML and Burhans WC: Mimosine arrests DNA synthesis at replication forks by inhibiting deoxyribonucleotide metabolism. J Biol Chem. 270:9597–9606. 1995. View Article : Google Scholar : PubMed/NCBI
12	Kalejta RF and Hamlin JL: The dual effect of mimosine on DNA replication. Exp Cell Res. 231:173–183. 1997. View Article : Google Scholar : PubMed/NCBI
13	Krude T: Mimosine arrests proliferating human cells before onset of DNA replication in a dose-dependent manner. Exp Cell Res. 247:148–159. 1999. View Article : Google Scholar : PubMed/NCBI
14	Chang HC, Lee TH, Chuang LY, Yen MH and Hung WC: Inhibitory effect of mimosine on proliferation of human lung cancer cells is mediated by multiple mechanisms. Cancer Lett. 145:1–8. 1999. View Article : Google Scholar : PubMed/NCBI
15	Oppenheim EW, Nasrallah IM, Mastri MG and Stover PJ: Mimosine is a cell-specific antagonist of folate metabolism. J Biol Chem. 275:19268–19274. 2000. View Article : Google Scholar : PubMed/NCBI
16	Chang HC, Weng CF, Yen MH, Chuang LY and Hung WC: Modulation of cell cycle regulatory protein expression and suppression of tumor growth by mimosine in nude mice. Int J Oncol. 17:659–665. 2000.PubMed/NCBI
17	Dong Z and Zhang JT: EIF3 p170, a mediator of mimosine effect on protein synthesis and cell cycle progression. Mol Biol Cell. 14:3942–3951. 2003. View Article : Google Scholar : PubMed/NCBI
18	Shen J, Yin JY, Li XP, Liu ZQ, Wang Y, Chen J, Qu J, Xu XJ, McLeod HL, He YJ, et al: The prognostic value of altered eIF3a and its association with p27 in non-small cell lung cancers. PLoS One. 9:e960082014. View Article : Google Scholar : PubMed/NCBI
19	Staunton MJ and Gaffney EF: Tumor type is a determinant of susceptibility to apoptosis. Am J Clin Pathol. 103:300–307. 1995. View Article : Google Scholar : PubMed/NCBI
20	Fisher DE: Apoptosis in cancer therapy: Crossing the threshold. Cell. 78:539–542. 1994. View Article : Google Scholar : PubMed/NCBI
21	Fan S, Smith ML, Rivet DJ II, Duba D, Zhan Q, Kohn KW, Fornace AJ Jr and O'Connor PM: Disruption of p53 function sensitizes breast cancer MCF-7 cells to cisplatin and pentoxifylline. Cancer Res. 55:1649–1654. 1995.PubMed/NCBI
22	Le NT and Richardson DR: Iron chelators with high antiproliferative activity up-regulate the expression of a growth inhibitory and metastasis suppressor gene: A link between iron metabolism and proliferation. Blood. 104:2967–2975. 2004. View Article : Google Scholar : PubMed/NCBI
23	Zalatnai A: P-glycoprotein expression is induced in human pancreatic cancer xenografts during treatment with a cell cycle regulator, mimosine. Pathol Oncol Res. 11:164–169. 2005. View Article : Google Scholar : PubMed/NCBI
24	Elmore S: Apoptosis: A review of programmed cell death. Toxicol Pathol. 35:495–516. 2007. View Article : Google Scholar : PubMed/NCBI
25	Lavrik IN, Golks A and Krammer PH: Caspases: Pharmacological manipulation of cell death. J Clin Invest. 115:2665–2672. 2005. View Article : Google Scholar : PubMed/NCBI
26	Grütter MG: Caspases: Key players in programmed cell death. Curr Opin Struct Biol. 10:649–655. 2000. View Article : Google Scholar : PubMed/NCBI
27	Hata AN, Engelman JA and Faber AC: The BCL2 family: Key mediators of the apoptotic response to targeted anticancer therapeutics. Cancer Discov. 5:475–487. 2015. View Article : Google Scholar : PubMed/NCBI
28	Wei MC, Zong WX, Cheng EH, Lindsten T, Panoutsakopoulou V, Ross AJ, Roth KA, MacGregor GR, Thompson CB and Korsmeyer SJ: Proapoptotic BAX and BAK: A requisite gateway to mitochondrial dysfunction and death. Science. 292:727–730. 2001. View Article : Google Scholar : PubMed/NCBI
29	Parsons MJ and Green DR: Mitochondria in cell death. Essays Biochem. 47:99–114. 2010. View Article : Google Scholar : PubMed/NCBI
30	Kantari C and Walczak H: Caspase-8 and bid: Caught in the act between death receptors and mitochondria. Biochim Biophys Acta. 1813:558–563. 2011. View Article : Google Scholar : PubMed/NCBI
31	Kim B, Srivastava SK and Kim SH: Caspase-9 as a therapeutic target for treating cancer. Expert Opin Ther Targets. 19:113–127. 2015. View Article : Google Scholar : PubMed/NCBI
32	Gu X and Manautou JE: Molecular mechanisms underlying chemical liver injury. Expert Rev Mol Med. 14:e42012. View Article : Google Scholar : PubMed/NCBI